How children's muscles repair themselves and what that could mean for muscle disease

Understanding regulation of pediatric regenerative myogenesis and its implication for muscle disease

NIH-funded research Children's Research Institute · NIH-11293415

This project looks at why children's muscles heal so well and how that knowledge could help kids with early-onset muscle diseases like Duchenne muscular dystrophy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionChildren's Research Institute NIH-funded
Lab location1 site (Washington, United States)
Project IDNIH-11293415 on NIH RePORTER

What this research studies

From the patient's perspective, researchers are trying to understand why pediatric muscles regenerate faster and more completely than adult muscles by studying the cells and signals in the muscle environment. They will compare healthy pediatric muscle with dystrophic muscle to see which immune and support-cell interactions help or hinder repair. The team will use lab models and tissue-based experiments to identify points that could be targeted to boost regeneration. The goal is to find approaches that could eventually be turned into treatments to protect or improve muscle function in children with degenerative muscle diseases.

Who could benefit from this research

Good fit: Ideal candidates would be children with early-onset degenerative muscle diseases such as Duchenne muscular dystrophy, or families willing to provide tissue samples for research.

Not a fit: Adults with age-related muscle loss or people with unrelated medical conditions are unlikely to see direct benefits from this pediatric-focused work.

Why it matters

Potential benefit: If successful, this work could point to new therapies that help children's muscles regenerate better and slow the progression of diseases like Duchenne muscular dystrophy.

How similar studies have performed: Prior laboratory studies have improved muscle repair in models, but focusing on the pediatric muscle niche as a therapeutic target is a newer approach with limited direct clinical success so far.

Where this research is happening

Washington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.